Differential proteomic analysis of late-stage and recurrent breast cancer from formalin-fixed paraffin-embedded tissues

Journal of Proteome Research

Volumn 10, Issue 3, 2011, Pages 1323-1332

  Bateman, Nicholas W ^a   Sun, Mai ^a   Bhargava, Rohit ^a   Hood, Brian L ^a   Darfler, Marlene M ^b   Kovatich, Albert J ^c   Hooke, Jeffrey A ^c   Krizman, David B ^b   Conrads, Thomas P ^a,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Expression Pathology Inc   (United States)

^c MDR Global Systems LLC   (United States)

^d BETTY AND GUY BEATTY CENTER FOR INTEGRATED RESEARCH   (United States)

Author keywords

breast cancer; formalin fixed paraffin embedded; laser microdissection; mass spectrometry; proteomics

Indexed keywords

THROMBOSPONDIN 1; UVOMORULIN;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FUNCTIONAL PROTEOMICS; HUMAN; HUMAN TISSUE; MASS SPECTROMETRY; PRIORITY JOURNAL;

ADULT; AGED; ANIMALS; BREAST NEOPLASMS; CHROMATOGRAPHY, LIQUID; DISEASE PROGRESSION; FEMALE; FIXATIVES; FORMALDEHYDE; HUMANS; MIDDLE AGED; NEOPLASM PROTEINS; PARAFFIN EMBEDDING; PROTEOME; RECURRENCE; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL;

EID: 79952392534     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr101073s     Document Type: Article

References (65)

1. Jemal, A.; Siegel, R.; Xu, J.; Ward, E. Cancer Statistics CA Cancer J Clin. 2010, 60, 277-300
2. Maughan, K. L.; Lutterbie, M. A.; Ham, P. S. Treatment of breast cancer Am. Fam. Physician 2010, 81 (11) 1339-46
3. Hayes, D. F., Tumor node metastasis (TNM) staging classification for breast cancer. In UpToDate; Basow, D. S., Ed.; UpToDate: Waltham, MA, 2010.
4. Carey, L. A.; Metzger, R.; Dees, E. C.; Collichio, F.; Sartor, C. I.; Ollila, D. W.; Klauber-DeMore, N.; Halle, J.; Sawyer, L.; Moore, D. T.; Graham, M. L. American Joint Committee on Cancer tumor-node-metastasis stage after neoadjuvant chemotherapy and breast cancer outcome J. Natl. Cancer Inst. 2005, 97 (15) 1137-42 (Pubitemid 41511213)
5. Martin, M.; Gonzalez Palacios, F.; Cortes, J.; de la Haba, J.; Schneider, J. Prognostic and predictive factors and genetic analysis of early breast cancer Clin. Transl. Onco. 2009, 11 (10) 634-42
6. Bhargava, R.; Beriwal, S.; Dabbs, D. J.; Ozbek, U.; Soran, A.; Johnson, R. R.; Brufsky, A. M.; Lembersky, B. C.; Ahrendt, G. M. Immunohistochemical surrogate markers of breast cancer molecular classes predicts response to neoadjuvant chemotherapy: a single institutional experience with 359 cases Cancer 2010, 116 (6) 1431-9
7. Perou, C. M.; Sorlie, T.; Eisen, M. B.; van de Rijn, M.; Jeffrey, S. S.; Rees, C. A.; Pollack, J. R.; Ross, D. T.; Johnsen, H.; Akslen, L. A.; Fluge, O.; Pergamenschikov, A.; Williams, C.; Zhu, S. X.; Lonning, P. E.; Borresen-Dale, A. L.; Brown, P. O.; Botstein, D. Molecular portraits of human breast tumours Nature 2000, 406 (6797) 747-52
8. Harris, L.; Fritsche, H.; Mennel, R.; Norton, L.; Ravdin, P.; Taube, S.; Somerfield, M. R.; Hayes, D. F.; Bast, R. C., Jr. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer J. Clin. Oncol. 2007, 25 (33) 5287-312 (Pubitemid 350232263)
9. Jeffrey, S. S.; Lonning, P. E.; Hillner, B. E. Genomics-based prognosis and therapeutic prediction in breast cancer J. Natl. Compr. Cancer Network 2005, 3 (3) 291-300 (Pubitemid 44265435)
10. Kim, C.; Paik, S. Gene-expression-based prognostic assays for breast cancer Nat. Rev. Clin. Oncol. 2010, 7 (6) 340-7
11. Sorlie, T.; Perou, C. M.; Tibshirani, R.; Aas, T.; Geisler, S.; Johnsen, H.; Hastie, T.; Eisen, M. B.; van de Rijn, M.; Jeffrey, S. S.; Thorsen, T.; Quist, H.; Matese, J. C.; Brown, P. O.; Botstein, D.; Eystein Lonning, P.; Borresen-Dale, A. L. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc. Natl. Acad. Sci. U.S.A. 2001, 98 (19) 10869-74 (Pubitemid 32878711)
12. van t Veer, L. J.; Dai, H.; van de Vijver, M. J.; He, Y. D.; Hart, A. A.; Mao, M.; Peterse, H. L.; van der Kooy, K.; Marton, M. J.; Witteveen, A. T.; Schreiber, G. J.; Kerkhoven, R. M.; Roberts, C.; Linsley, P. S.; Bernards, R.; Friend, S. H. Gene expression profiling predicts clinical outcome of breast cancer Nature 2002, 415 (6871) 530-6 (Pubitemid 34130608)
13. Carey, L. A., Prognostic molecular profiles of breast cancer. In UpToDate; Basow, D. S., Ed.; UpToDate: Waltham, MA, 2010.
14. Tsuda, H. Individualization of breast cancer based on histopathological features and molecular alterations Breast Cancer 2008, 15 (2) 121-32
15. Burness, M. L.; Grushko, T. A.; Olopade, O. I. Epidermal growth factor receptor in triple-negative and basal-like breast cancer: promising clinical target or only a marker? Cancer J. 2010, 16 (1) 23-32
16. Hood, B. L.; Conrads, T. P.; Veenstra, T. D. Mass spectrometric analysis of formalin-fixed paraffin-embedded tissue: unlocking the proteome within Proteomics 2006, 6 (14) 4106-14
17. Abramovitz, M.; Leyland-Jones, B. A systems approach to clinical oncology: focus on breast cancer Proteome Sci. 2006, 4, 5
18. Gnanapragasam, V. J. Unlocking the molecular archive: the emerging use of formalin-fixed paraffin-embedded tissue for biomarker research in urological cancer BJU Int. 2010, 105 (2) 274-8
19. Berg, D.; Hipp, S.; Malinowsky, K.; Bollner, C.; Becker, K. F. Molecular profiling of signalling pathways in formalin-fixed and paraffin-embedded cancer tissues Eur. J. Cancer 2010, 46 (1) 47-55
20. Hood, B. L.; Darfler, M. M.; Guiel, T. G.; Furusato, B.; Lucas, D. A.; Ringeisen, B. R.; Sesterhenn, I. A.; Conrads, T. P.; Veenstra, T. D.; Krizman, D. B. Proteomic analysis of formalin-fixed prostate cancer tissue Mol. Cell. Proteomics 2005, 4 (11) 1741-53 (Pubitemid 41749267)
21. Shi, S. R.; Liu, C.; Balgley, B. M.; Lee, C.; Taylor, C. R. Protein extraction from formalin-fixed, paraffin-embedded tissue sections: quality evaluation by mass spectrometry J. Histochem. Cytochem. 2006, 54 (6) 739-43 (Pubitemid 43736896)
22. Hood, B. L.; Conrads, T. P.; Veenstra, T. D. Unravelling the proteome of formalin-fixed paraffin-embedded tissue Brief Funct. Genomic Proteomic 2006, 5 (2) 169-75 (Pubitemid 46403009)
23. Becker, K. F.; Schott, C.; Hipp, S.; Metzger, V.; Porschewski, P.; Beck, R.; Nahrig, J.; Becker, I.; Hofler, H. Quantitative protein analysis from formalin-fixed tissues: implications for translational clinical research and nanoscale molecular diagnosis J. Pathol. 2007, 211 (3) 370-8 (Pubitemid 46172713)
24. Patel, V.; Hood, B. L.; Molinolo, A. A.; Lee, N. H.; Conrads, T. P.; Braisted, J. C.; Krizman, D. B.; Veenstra, T. D.; Gutkind, J. S. Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression Clin. Cancer Res. 2008, 14 (4) 1002-14 (Pubitemid 351302545)
25. Ronci, M.; Bonanno, E.; Colantoni, A.; Pieroni, L.; Di Ilio, C.; Spagnoli, L. G.; Federici, G.; Urbani, A. Protein unlocking procedures of formalin-fixed paraffin-embedded tissues: application to MALDI-TOF imaging MS investigations Proteomics 2008, 8 (18) 3702-14
26. Elias, J. E.; Gygi, S. P. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry Nat. Methods 2007, 4 (3) 207-14 (Pubitemid 46358868)
27. Marengo, E.; Robotti, E.; Bobba, M.; Gosetti, F. The principle of exhaustiveness versus the principle of parsimony: a new approach for the identification of biomarkers from proteomic spot volume datasets based on principal component analysis Anal. Bioanal. Chem. 2010, 397 (1) 25-41
28. Ferguson, R. E.; Carroll, H. P.; Harris, A.; Maher, E. R.; Selby, P. J.; Banks, R. E. Housekeeping proteins: a preliminary study illustrating some limitations as useful references in protein expression studies Proteomics 2005, 5 (2) 566-71 (Pubitemid 40262073)
29. Kass, L.; Erler, J. T.; Dembo, M.; Weaver, V. M. Mammary epithelial cell: influence of extracellular matrix composition and organization during development and tumorigenesis Int. J. Biochem. Cell Biol. 2007, 39 (11) 1987-94 (Pubitemid 47369248)
30. Bissell, M. J.; Radisky, D. Putting tumours in context Nat. Rev. Cancer 2001, 1 (1) 46-54 (Pubitemid 33741880)
31. Bissell, M. J.; Weaver, V. M.; Lelievre, S. A.; Wang, F.; Petersen, O. W.; Schmeichel, K. L. Tissue structure, nuclear organization, and gene expression in normal and malignant breast Cancer Res. 1999, 59 (7 Suppl) 1757-63s
32. Discussion: 1763s-4s.
33. Hahn, W. C.; Weinberg, R. A. Modelling the molecular circuitry of cancer Nat. Rev. Cancer 2002, 2 (5) 331-41 (Pubitemid 37328946)
34. Hanahan, D.; Weinberg, R. A. The hallmarks of cancer Cell 2000, 100 (1) 57-70 (Pubitemid 30046295)
35. Amatschek, S.; Koenig, U.; Auer, H.; Steinlein, P.; Pacher, M.; Gruenfelder, A.; Dekan, G.; Vogl, S.; Kubista, E.; Heider, K. H.; Stratowa, C.; Schreiber, M.; Sommergruber, W. Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes Cancer Res. 2004, 64 (3) 844-56 (Pubitemid 38176883)
36. Levental, K. R.; Yu, H.; Kass, L.; Lakins, J. N.; Egeblad, M.; Erler, J. T.; Fong, S. F.; Csiszar, K.; Giaccia, A.; Weninger, W.; Yamauchi, M.; Gasser, D. L.; Weaver, V. M. Matrix crosslinking forces tumor progression by enhancing integrin signaling Cell 2009, 139 (5) 891-906
37. Martin, L. J.; Boyd, N. F. Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence Breast Cancer Res. 2008, 10 (1) 201
38. Schuetz, C. S.; Bonin, M.; Clare, S. E.; Nieselt, K.; Sotlar, K.; Walter, M.; Fehm, T.; Solomayer, E.; Riess, O.; Wallwiener, D.; Kurek, R.; Neubauer, H. J. Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis Cancer Res. 2006, 66 (10) 5278-86 (Pubitemid 43844952)
39. Pereira, M. B.; Dias, A. J.; Reis, C. A.; Schmitt, F. C. Immunohistochemical study of the expression of MUC5AC and MUC6 in breast carcinomas and adjacent breast tissues J. Clin. Pathol. 2001, 54 (3) 210-3 (Pubitemid 32205042)
40. Rakha, E. A.; Boyce, R. W.; Abd El-Rehim, D.; Kurien, T.; Green, A. R.; Paish, E. C.; Robertson, J. F.; Ellis, I. O. Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer Mod. Pathol. 2005, 18 (10) 1295-304 (Pubitemid 41348648)
41. Rice, A.; Quinn, C. M. Angiogenesis, thrombospondin, and ductal carcinoma in situ of the breast J. Clin. Pathol. 2002, 55 (8) 569-74
42. Turashvili, G.; Bouchal, J.; Burkadze, G.; Kolar, Z. Differentiation of tumours of ductal and lobular origin: I. Proteomics of invasive ductal and lobular breast carcinomas Biomed. Pap. Med. Fac. Palacky Univ. Olomouc 2005, 149 (1) 57-62
43. Locopo, N.; Fanelli, M.; Gasparini, G. Clinical significance of angiogenic factors in breast cancer Breast Cancer Res. Treat. 1998, 52 (1-3) 159-73 (Pubitemid 29056093)
44. Rice, A. J.; Steward, M. A.; Quinn, C. M. Thrombospondin 1 protein expression relates to good prognostic indices in ductal carcinoma in situ of the breast J. Clin. Pathol. 2002, 55 (12) 921-5 (Pubitemid 35454494)
45. Wong, S. Y.; Purdie, A. T.; Han, P. Thrombospondin and other possible related matrix proteins in malignant and benign breast disease. An immunohistochemical study Am. J. Pathol. 1992, 140 (6) 1473-82
46. Cowin, P.; Rowlands, T. M.; Hatsell, S. J. Cadherins and catenins in breast cancer Curr. Opin. Cell Biol. 2005, 17 (5) 499-508 (Pubitemid 41267164)
47. Heimann, R.; Lan, F.; McBride, R.; Hellman, S. Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin Cancer Res. 2000, 60 (2) 298-304 (Pubitemid 30070755)
48. Rimm, D. L.; Sinard, J. H.; Morrow, J. S. Reduced alpha-catenin and E-cadherin expression in breast cancer Lab. Invest. 1995, 72 (5) 506-12
49. De Leeuw, W. J.; Berx, G.; Vos, C. B.; Peterse, J. L.; Van de Vijver, M. J.; Litvinov, S.; Van Roy, F.; Cornelisse, C. J.; Cleton-Jansen, A. M. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ J. Pathol. 1997, 183 (4) 404-11 (Pubitemid 27509246)
50. Gaspar, C.; Franken, P.; Molenaar, L.; Breukel, C.; van der Valk, M.; Smits, R.; Fodde, R. A targeted constitutive mutation in the APC tumor suppressor gene underlies mammary but not intestinal tumorigenesis PLoS Genet. 2009, 5 (7) e1000547
51. Wang, X.; Goode, E. L.; Fredericksen, Z. S.; Vierkant, R. A.; Pankratz, V. S.; Liu-Mares, W.; Rider, D. N.; Vachon, C. M.; Cerhan, J. R.; Olson, J. E.; Couch, F. J. Association of genetic variation in genes implicated in the beta-catenin destruction complex with risk of breast cancer Cancer Epidemiol. Biomarkers Prev. 2008, 17 (8) 2101-8
52. Prasad, C. P.; Mirza, S.; Sharma, G.; Prashad, R.; DattaGupta, S.; Rath, G.; Ralhan, R. Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast Life Sci. 2008, 83 (9-10) 318-25
53. Kruser, T. J.; Wheeler, D. L. Mechanisms of resistance to HER family targeting antibodies Exp. Cell Res. 2010, 316 (7) 1083-100
54. Goldfarb, Y.; Ben-Eliyahu, S. Surgery as a risk factor for breast cancer recurrence and metastasis: mediating mechanisms and clinical prophylactic approaches Breast Dis. 2006, 26, 99-114 (Pubitemid 46655482)
55. Smith, M. J.; Culhane, A. C.; Killeen, S.; Kelly, M. A.; Wang, J. H.; Cotter, T. G.; Redmond, H. P. Mechanisms driving local breast cancer recurrence in a model of breast-conserving surgery Ann. Surg. Oncol. 2008, 15 (10) 2954-64
56. Kim, D. H.; Bae, J.; Lee, J. W.; Kim, S.; Kim, Y.; Bae, J.; Yi, J. K.; Yu, M.; Noh, D. Y.; Lee, C. Proteomic analysis of breast cancer tissue reveals upregulation of actin-remodeling proteins and its relevance to cancer invasiveness Proteomics: Clin. Appl. 2009, 3 (1) 30-40
57. Wagner, C.; Koury, M. J. S-Adenosylhomocysteine: a better indicator of vascular disease than homocysteine? Am. J. Clin. Nutr. 2007, 86 (6) 1581-5 (Pubitemid 350232170)
58. Lukyanova, N. Y. Characteristics of homocysteine-induced multidrug resistance of human MCF-7 breast cancer cells and human A2780 ovarian cancer cells Exp. Oncol. 2010, 32 (1) 10-4
59. Kahle, P. J.; Waak, J.; Gasser, T. DJ-1 and prevention of oxidative stress in Parkinsons disease and other age-related disorders Free Radic. Biol. Med. 2009, 47 (10) 1354-61
60. Kim, R. H.; Peters, M.; Jang, Y.; Shi, W.; Pintilie, M.; Fletcher, G. C.; DeLuca, C.; Liepa, J.; Zhou, L.; Snow, B.; Binari, R. C.; Manoukian, A. S.; Bray, M. R.; Liu, F. F.; Tsao, M. S.; Mak, T. W. DJ-1, a novel regulator of the tumor suppressor PTEN Cancer Cell 2005, 7 (3) 263-73 (Pubitemid 40568685)
61. Le Naour, F.; Misek, D. E.; Krause, M. C.; Deneux, L.; Giordano, T. J.; Scholl, S.; Hanash, S. M. Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer Clin. Cancer Res. 2001, 7 (11) 3328-35 (Pubitemid 33069962)
62. Pucci-Minafra, I.; Cancemi, P.; Albanese, N. N.; Di Cara, G.; Marabeti, M. R.; Marrazzo, A.; Minafra, S. New protein clustering of breast cancer tissue proteomics using actin content as a cellularity indicator J. Proteome Res. 2008, 7 (4) 1412-8
63. Gibson, S. L.; Ma, Z.; Shaw, L. M. Divergent roles for IRS-1 and IRS-2 in breast cancer metastasis Cell Cycle 2007, 6 (6) 631-7 (Pubitemid 46535670)
64. Chan, B. T.; Lee, A. V. Insulin receptor substrates (IRSs) and breast tumorigenesis J. Mammary Gland Biol. Neoplasia 2008, 13 (4) 415-22
65. Rocha, R. L.; Hilsenbeck, S. G.; Jackson, J. G.; VanDenBerg, C. L.; Weng, C.; Lee, A. V.; Yee, D. Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival Clin. Cancer Res. 1997, 3 (1) 103-9 (Pubitemid 27079451)